Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eastern Bankshares Inc. Common Stock (EBC) vs Illumina, Inc. (ILMN) Price & Performance

Eastern Bankshares Inc. Common StockTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

Eastern Bankshares Inc. Common Stock vs Illumina, Inc. — how do they compare? Eastern Bankshares Inc. Common Stock trades at $20.77 (market cap $4.79B), while Illumina, Inc. trades at $271.84 (market cap $40.95B). The key difference: Illumina, Inc. is far larger — about 8.5× Eastern Bankshares Inc. Common Stock's market cap, and Eastern Bankshares Inc. Common Stock pays a 2.67% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eastern Bankshares Inc. Common Stock for 0 Days and Illumina, Inc. for 84 Days on average.

EBCILMN
Market Cap
$4.79B$40.95B
Volume
1,740,7161,893,606
Sector
FinancialsHealth
52-Week High
$23.65$293.69
52-Week Low
$16.73$93.00
Typical Hold Time
0 Days84 Days
Enterprise Value
$5.07B$42.31B
Dividend Yield
2.67%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eastern Bankshares Inc. Common Stock

Eastern Bankshares (EBC) trades at $20.96, down 0.85% on the day, with a neutral technical signal. The stock shows strong fundamentals, including a P/E of 11.71, net income margin of 33.47%, and recent Q2 2026 EPS beat. Analyst consensus is bullish with a $25.60 price target. Recent news highlights institutional buying and upcoming Q3 2026 earnings.

The outlook is positive given solid profitability, attractive valuation, and analyst support. Key risks include integration challenges from recent acquisitions and interest rate sensitivity. Upside potential exists if earnings momentum continues, but investors should monitor net cash flow trends and competitive pressures.

Illumina, Inc.

Illumina (ILMN) trades at $271.76, down 1.77% today but near its 52-week high of $278.99. The stock has surged 94.9% YTD, supported by strong earnings beats and positive technical momentum. Recent quarterly results exceeded expectations with Q2 2026 EPS of $1.31 beating the $1.23 estimate. The company shows improving fundamentals with 2025 net income of $850 million and robust operating cash flow of $1.08 billion.

ILMN presents growth potential through AI integration and S&P 500 inclusion, but faces risks from China headwinds and elevated valuations. Analyst consensus remains bullish with 54% buy ratings, though the $241 consensus price target suggests limited upside. Key catalysts include continued sequencing growth and margin expansion, while competition and cost volatility remain concerns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EBC
100% Buy0% Sell
Avg holding period · 0 Days
ILMN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Eastern Bankshares Inc. Common Stock

Eastern Bankshares, Inc. is the holding company for Eastern Bank, a Massachusetts-based bank operating more than 125 branches across eastern Massachusetts, southern and coastal New Hampshire, and Rhode Island, offering consumer and business banking along with wealth management through its Cambridge Trust divisions.

Read more on EBC →

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →